AH

ABIGAIL HEMENWAY

HOLLAND & KNIGHT LLP · Washington, DC · registered since 2024
Registered · LDAActive

At a glance

Registered since
2024
Senate LDA system
Clients
5
last 3 years
Filings
11
5 agencies contacted
Activity
filings by quarter
Works on

Background

Government experience
Staff Assistant
Senate Committee on Energy & Natural Resources; Staff Assistant, Legislative Correspondent, Legislative Aide, Sen. Lisa Murkowski
Disclosed on LD-2 filings
Career
Washington, DC
2024 - present

Specific issues

FY 2025 appropriations for the Department of Defense peer reviewed medical research program and Department of HHS, National Institutes of Health Office of the Director (both for mitochondrial disease research).
Budget/Appropriations · 2024 Q3
FY 2025 appropriations for the Department of Defense peer reviewed medical research program and Department of HHS, National Institutes of Health Office of the Director (both for mitochondrial disease research); Medical Nutrition Equity Act; Advancing Kids Access to Care Act; Rare Pediatric Disease Voucher Review Program; Telehealth Authority extension.
Health Issues · 2024 Q3
Advocacy for front line hospitals; statutory recognition of front line hospitals and Medicaid and Medicare funding for disproportionate share hospitals (H.R. 7327); demonstration program on physical and mental health comorbidities (S.3450); transparency issues and modernization related to 340B Drug Discount Program.
Health Issues · 2024 Q3
Advocacy for front line hospitals; statutory recognition of front line hospitals and Medicaid and Medicare funding for disproportionate share hospitals (H.R. 7327); demonstration program on physical and mental health comorbidities (S.3450); transparency issues related to 340B Drug Discount Program, site neutral legislation affecting front line hospitals.
Medicare/Medicaid · 2024 Q3
Veterans Administration funding of air ambulance services.
Veterans · 2024 Q3
Implementation and reauthorization of the Food and Drug Administration (FDA) over-the-counter (OTC) drug approval process reforms for sunscreen ingredients included in Public Law 116-136, the Coronavirus Aid, Relief, and Economic Security (CARES Act); FDA proposed order on OTC sunscreen active ingredients; FDA jurisdiction regarding the safety and efficacy and OTC sunscreen active ingredients; sunscreen provisions in the FY 2025 House and Senate appropriations for the Food and Drug Administration (H.R. 9027 and S. 4690); implementation of the National Academies of Science (NAS) report on sunscreen; skin cancer prevention for outdoor workers; Cancer Moonshot initiative; use of sunscreen in schools to prevent sunburns in children.
Medical/Disease Research/Clinical Labs · 2024 Q2

Clients

$██,███ / qtrUnlock
$██,███ / qtrUnlock
$██,███ / qtrUnlock
$██,███ / qtrUnlock
$██,███ / qtrUnlock

Filing history

2024 Q3
UNITED MITOCHONDRIAL DISEASE FOUNDATION
Q3lda.gov →
2024 Q3
FRONT LINE HOSPITAL ALLIANCE
Q3lda.gov →
2024 Q3
ASSOCIATION OF CRITICAL CARE TRANSPORT
Q3lda.gov →
2024 Q2
PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION
Q2lda.gov →
2024 Q2
UNITED MITOCHONDRIAL DISEASE FOUNDATION
Q2lda.gov →
2024 Q2
ASSOCIATION OF CRITICAL CARE TRANSPORT
Q2lda.gov →
2024 Q2
FRONT LINE HOSPITAL ALLIANCE
Q2lda.gov →
2024 Q2
NATIONAL ASSOCIATION OF EMS PHYSICIANS
Q2lda.gov →
2024 Q1
FRONT LINE HOSPITAL ALLIANCE
Q1lda.gov →
2024 Q1
NATIONAL ASSOCIATION OF EMS PHYSICIANS
Q1lda.gov →
2024 Q1
PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION
Q1lda.gov →
Showing recent filings · full history on lda.gov